Table 2 Proportion diagnosed in primary care and proportion of surgically treated patients with ulnar nerve entrapment (UNE) at any level and registered in the Skåne Health Care Register (SHR) and the Swedish National Diabetes Register (NDR) during 2004–2019.

From: Presurgical management of ulnar nerve entrapment in patients with and without diabetes mellitus

 

Level of care (primary care)

Surgically treated

All patients

449 (7.0)

2389 (37.0)

 Men

229 (7.2)

1228 (38.5)

 Women

220 (6.7)

1161 (35.6)

No diabetes

425 (7.4)

2131 (36.8)

Diabetes

24 (3.6)

258 (38.7)

 Type 1

2 (1.6)

43 (35.0)

 Type 2

22 (4.0)

215 (39.5)

Glycemic control

 Optimal

13 (5.6)

88 (38.4)

 Acceptable

8 (3.6)

82 (36.6)

 Poor

3 (1.4)

88 (41.1)

 Retinopathy

8 (2.7)

131 (39.0)

 No retinopathy

15 (4.5)

118 (39.7)

Level of care

 Primary care

 

59 (13.1)

 Specialist care

 

2330 (38.8)

  1. Values presented as n (%). Level of care refers to where the patients had their first UNE diagnosis. Surgically treated patients include patients with at least one registered surgical procedure for UNE at any level during the study period. Glycemic control is defined as optimal (HbA1c ≤ 51.1 mmol/mol), acceptable (HbA1c 51.2–63.7 mmol/mol), and poor (HbA1c > 63.7 mmol/mol).